ClinConnect ClinConnect Logo
Search / Trial NCT03155477

Effect Of Curcuma Xanthorrhiza and Vitamin D3 Supplementation in SLE Patients With Hypovitamin D

Launched by SAIFUL ANWAR HOSPITAL · May 13, 2017

Trial Information

Current as of June 03, 2025

Completed

Keywords

Sle, Vitamin D, Sledai, Il 6, Tgf β1

ClinConnect Summary

Cholecalciferol 1200 IU supplementation for 3 months in hypovitamin D SLE patients, decrease SLEDAI, however, it has not reached the mild activity and remission yet. Curcumin contained in Curcuma Xanthorrhiza; is an immunomodulator that has similar biological effect with vitamin D. Combination of curcumin and vitamin D are expected to work synergistically.

The subjects who fulfilled inclusion criteria, willing to participate in the research and signed the informed consent were 40 patients. Research subjects were randomized using simple randomization. The subjects were divided into 2 groups...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • SLE based on the criteria of American Collage of Rheumatology (ACR) 1997
  • Active SLE (SLEDAI\> 3)
  • 25(OH)D level \<30 ng/ml.
  • Exclusion Criteria:
  • Pregnant
  • Taking supplements containing vitamin D and cur cumin
  • Had liver function disorders (SGOT/SGPT levels\> 2.5 times the upper normal limit)
  • Had impaired renal function (GFR \<25 ml/min)
  • Severe infections such as tuberculosis, pneumonia or HIV

About Saiful Anwar Hospital

Saiful Anwar Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Renowned for its commitment to quality care and state-of-the-art facilities, the hospital actively engages in a variety of clinical studies aimed at evaluating new therapies, medical devices, and treatment protocols. With a multidisciplinary team of experienced healthcare professionals, Saiful Anwar Hospital prioritizes patient safety and ethical standards while contributing valuable insights to the medical community. The hospital's strategic focus on collaboration and excellence positions it as a pivotal player in the landscape of clinical research.

Locations

Patients applied

0 patients applied

Trial Officials

Handono Kalim, Prof.

Principal Investigator

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials